Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SCOR in Targeted Therapies for Infant Leukemias Project 4: MicroRNA Sequencing of Infant AML

NCT01229124 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01229124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01229124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SCOR in Targeted Therapies for Infant Leukemias Project 4: MicroRNA Sequencing of Infant AML
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
May 31, 2016
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia